Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vastra Gotaland Region
With
Swedish Heart Lung Foundation
Göteborg University
Lund University
Uppsala University
Please see attached analysis plan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients starting PAP treatment for OSA in the swedevox registry between 2010-2021 with and without hypertension. Randomly selected controls with and without hypertension from the general population.
You may not be if
Patients with manifest cardiovascular disease (stroke, ischemic heart disease, cardiac failure or atrial fibrillation at baseline).
Patients with kidney failure at baseline.
Patients with malignant cancer at baseline.
Subjects with missing data on any of the main variables in the fitted models.
Clareo Health | Primary Prevention Long-term Registry Study in OSA and Hypertension. Survival Analysis 2010-2022
